FindTrial
Sign In

Clinical features and prognosis of newly diagnosed HIV-associated lymphoma in the combined antiretroviral era: a retrospective cohort study

Clinical features and prognosis of newly diagnosed HIV-associated lymphoma in the combined antiretroviral era: a retrospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100054581
Enrollment
Unknown
Registered
2021-12-20
Start date
2013-12-09
Completion date
Unknown
Last updated
2022-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV associated lymphoma

Interventions

Case series:No

Sponsors

Affiliated Cancer Hospital of Chongqing University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Newly diagnosed patients with human immunodeficiency virus-associated lymphoma.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Clinical characteristics and prognose;—

Countries

China

Contacts

Public ContactLiu Yao

Affiliated Cancer Hospital of Chongqing University

wangchaoyu1990@126.com+86 13228684685

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026